3,4-Dichloromethylphenidate

A stimulant drug related to methylphenidate

3,4-Dichloromethylphenidate
3,4-dichloromethylphenidate.png
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

3,4-Dichloromethylphenidate (3,4-DCMP) is a stimulant drug that is chemically related to methylphenidate. It is known for its effects on the central nervous system and is used in research settings to study its pharmacological properties.

Chemical structure and properties

3,4-Dichloromethylphenidate is a derivative of methylphenidate, with two chlorine atoms substituted at the 3 and 4 positions of the phenyl ring. This modification alters its pharmacokinetic and pharmacodynamic properties compared to methylphenidate.

Pharmacology

3,4-DCMP acts primarily as a dopamine reuptake inhibitor, similar to methylphenidate. This action increases the concentration of dopamine in the synaptic cleft, leading to enhanced dopaminergic neurotransmission. The presence of chlorine atoms in its structure may affect its binding affinity and selectivity for dopamine transporters.

Uses

While 3,4-DCMP is not approved for medical use, it is utilized in scientific research to explore its potential effects on the brain and behavior. Studies may investigate its impact on attention, memory, and cognitive function.

Safety and legal status

As a research chemical, 3,4-DCMP is not regulated in the same manner as prescription medications. However, its legal status may vary by country, and it is important for researchers to comply with local regulations when handling this compound.

Related compounds

• Methylphenidate
• Dexmethylphenidate
• Ethylphenidate
• 4-Methylmethylphenidate

See also

• Stimulant
• Dopamine reuptake inhibitor
• Central nervous system

Related pages

• Attention deficit hyperactivity disorder
• Psychostimulant
• Neurotransmitter

3,4-Dichloromethylphenidate

• 
  3,4-Dichloromethylphenidate